<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE ep-patent-document PUBLIC "-//EPO//EP PATENT DOCUMENT 1.7//EN" "ep-patent-document-v1-7.dtd">
<!-- This XML data has been generated under the supervision of the European Patent Office -->
<ep-patent-document id="EP16916449B8W1" file="EP16916449W1B8.xml" lang="en" country="EP" doc-number="3515938" kind="B8" correction-code="W1" date-publ="20250430" status="c" dtd-version="ep-patent-document-v1-7">
<SDOBI lang="en"><B000><eptags><B001EP>ATBECHDEDKESFRGBGRITLILUNLSEMCPTIESILTLVFIROMKCYALTRBGCZEEHUPLSK..HRIS..MTNORS..SM..................</B001EP><B003EP>*</B003EP><B005EP>J</B005EP><B007EP>0009290-CORR01</B007EP></eptags></B000><B100><B110>3515938</B110><B120><B121>CORRECTED EUROPEAN PATENT SPECIFICATION</B121></B120><B130>B8</B130><B132EP>B1</B132EP><B140><date>20250430</date></B140><B150><B151>W1</B151><B153>73</B153><B155><B1551>de</B1551><B1552>Bibliographie</B1552><B1551>en</B1551><B1552>Bibliography</B1552><B1551>fr</B1551><B1552>Bibliographie</B1552></B155></B150><B190>EP</B190></B100><B200><B210>16916449.8</B210><B220><date>20160921</date></B220><B240><B241><date>20190418</date></B241><B242><date>20220516</date></B242></B240><B250>en</B250><B251EP>en</B251EP><B260>en</B260></B200><B400><B405><date>20250430</date><bnum>202518</bnum></B405><B430><date>20190731</date><bnum>201931</bnum></B430><B450><date>20250108</date><bnum>202502</bnum></B450><B452EP><date>20240730</date></B452EP><B480><date>20250430</date><bnum>202518</bnum></B480></B400><B500><B510EP><classification-ipcr sequence="1"><text>C07K  16/28        20060101AFI20200507BHEP        </text></classification-ipcr><classification-ipcr sequence="2"><text>A61K  39/395       20060101ALI20200507BHEP        </text></classification-ipcr><classification-ipcr sequence="3"><text>A61P  35/00        20060101ALI20200507BHEP        </text></classification-ipcr><classification-ipcr sequence="4"><text>C12N  15/13        20060101ALI20200507BHEP        </text></classification-ipcr><classification-ipcr sequence="5"><text>C12N  15/63        20060101ALI20200507BHEP        </text></classification-ipcr><classification-ipcr sequence="6"><text>C12N   5/10        20060101ALI20200507BHEP        </text></classification-ipcr><classification-ipcr sequence="7"><text>C12N   5/20        20060101ALI20200507BHEP        </text></classification-ipcr></B510EP><B520EP><classifications-cpc><classification-cpc sequence="1"><text>C07K  16/2818      20130101 LI20180817BHEP        </text></classification-cpc><classification-cpc sequence="2"><text>A61K2039/505       20130101 LA20180817BHEP        </text></classification-cpc><classification-cpc sequence="3"><text>C07K2317/24        20130101 LA20180817BHEP        </text></classification-cpc><classification-cpc sequence="4"><text>C07K2317/33        20130101 LA20180817BHEP        </text></classification-cpc><classification-cpc sequence="5"><text>C07K2317/34        20130101 LA20180817BHEP        </text></classification-cpc><classification-cpc sequence="6"><text>C07K2317/56        20130101 LA20180817BHEP        </text></classification-cpc><classification-cpc sequence="7"><text>C07K2317/74        20130101 LA20180817BHEP        </text></classification-cpc><classification-cpc sequence="8"><text>C07K2317/76        20130101 LA20180817BHEP        </text></classification-cpc><classification-cpc sequence="9"><text>C07K2317/92        20130101 LA20180817BHEP        </text></classification-cpc><classification-cpc sequence="10"><text>A61P  35/00        20180101 FI20180518BHEP        </text></classification-cpc></classifications-cpc></B520EP><B540><B541>de</B541><B542>MONOKLONALE ANTIKÖRPER GEGEN DEN PROGRAMMIERTEN TOD 1 (PD-1)</B542><B541>en</B541><B542>MONOCLONAL ANTIBODIES TO PROGRAMMED DEATH 1 (PD-1)</B542><B541>fr</B541><B542>ANTICORPS MONOCLONAUX DIRIGÉS CONTRE LA MORT PROGRAMMÉE 1 (PD -1)</B542></B540><B560><B561><text>WO-A1-2013/148250</text></B561><B561><text>WO-A1-2015/112900</text></B561><B561><text>WO-A1-2015/112900</text></B561><B561><text>WO-A2-2016/077397</text></B561><B561><text>WO-A2-2016/127179</text></B561><B561><text>CA-A1- 2 955 541</text></B561><B562><text>ANONYMOUS: "Assessment report OPDIVO International non-proprietary name: nivolumab Procedure No. EMEA/H/C/003985/0000", EMA/CHMP/76688/2015, 23 April 2015 (2015-04-23), pages 1 - 130, XP093186112</text></B562><B562><text>WANG, C. ET AL.: "In Vitro Characterization of the Anti-PD-1 Antibody Nivolumab, BMS-936558, and In Vivo Toxicology in Non-Human Primates", CANCER IMMUNOL RES., vol. 2, 28 May 2014 (2014-05-28), XP055206944</text></B562><B565EP><date>20200513</date></B565EP></B560></B500><B600><B620EP><parent><cdoc><dnum><anum>24184760.7</anum><pnum>4450616</pnum></dnum><date>20240626</date></cdoc></parent></B620EP></B600><B700><B720><B721><snm>ZHENG, Yong</snm><adr><str>Room 601
No. 48 Lane 618 Qingtong Road
Pudong District</str><city>Shanghai 201203</city><ctry>CN</ctry></adr></B721><B721><snm>LI, Jing</snm><adr><str>11 Dunham Street</str><city>Lexington, Massachusetts 02420</city><ctry>US</ctry></adr></B721><B721><snm>GOLOLOBOV, Gennady</snm><adr><str>204 Ridgepoint Place</str><city>Gaithersburg, Maryland 20878</city><ctry>US</ctry></adr></B721><B721><snm>ZHANG, Xinhua</snm><adr><str>Room 502
No. 46 Lane 336 Minyu Road
Pudong District</str><city>Shanghai 201209</city><ctry>CN</ctry></adr></B721><B721><snm>YANG, Baotian</snm><adr><str>Room 502
No. 39 Lane 380 Xiabi Road
Pudong District</str><city>Shanghai 200137</city><ctry>CN</ctry></adr></B721><B721><snm>TANG, Zhewei</snm><adr><str>Room 101
No. 6 Lane 811 Boshandong Road
Pudong District</str><city>Shanghai 200136</city><ctry>CN</ctry></adr></B721><B721><snm>LI, Dong</snm><adr><str>Room 1102
No. 44 Lane 398 Hanqing Road
Baoshan District</str><city>Shanghai 200444</city><ctry>CN</ctry></adr></B721><B721><snm>XU, Jianqing</snm><adr><str>Room 402
No. 37
Lane 4850
Chuansha Road
Pudong District</str><city>Shanghai 201200</city><ctry>CN</ctry></adr></B721><B721><snm>WANG, Zhuozhi</snm><adr><str>Unit 383
1388 Broadway</str><city>Millbrae, California 94030</city><ctry>US</ctry></adr></B721></B720><B730><B731><snm>CSTONE PHARMACEUTICALS</snm><iid>101735933</iid><irf>C32277WOEP</irf><adr><str>P.O. Box 31119, Grand Pavilion
Hibiscus Way
802 West Bay Road</str><city>KY1-1205 Grand Cayman</city><ctry>KY</ctry></adr></B731><B731><snm>CSTONE PHARMACEUTICALS (SUZHOU) CO., LTD.</snm><iid>102085167</iid><irf>C32277WOEP</irf><adr><str>218 Xinghu St, Building A1 E168
Suzhou Industrial Park</str><city>Jiangsu 215123</city><ctry>CN</ctry></adr></B731><B731><snm>CSTONE PHARMACEUTICALS (SHANGHAI) CO., LTD.</snm><iid>101735918</iid><irf>C32277WOEP</irf><adr><str>Room 211-20, Building 1
38 Debao Road
Pilot Free Trade Zone</str><city>Shanghai 200000</city><ctry>CN</ctry></adr></B731></B730><B740><B741><snm>Engelhard, Markus</snm><iid>101156514</iid><adr><str>Boehmert &amp; Boehmert
Anwaltspartnerschaft mbB
Pettenkoferstrasse 22</str><city>80336 München</city><ctry>DE</ctry></adr></B741></B740></B700><B800><B840><ctry>AL</ctry><ctry>AT</ctry><ctry>BE</ctry><ctry>BG</ctry><ctry>CH</ctry><ctry>CY</ctry><ctry>CZ</ctry><ctry>DE</ctry><ctry>DK</ctry><ctry>EE</ctry><ctry>ES</ctry><ctry>FI</ctry><ctry>FR</ctry><ctry>GB</ctry><ctry>GR</ctry><ctry>HR</ctry><ctry>HU</ctry><ctry>IE</ctry><ctry>IS</ctry><ctry>IT</ctry><ctry>LI</ctry><ctry>LT</ctry><ctry>LU</ctry><ctry>LV</ctry><ctry>MC</ctry><ctry>MK</ctry><ctry>MT</ctry><ctry>NL</ctry><ctry>NO</ctry><ctry>PL</ctry><ctry>PT</ctry><ctry>RO</ctry><ctry>RS</ctry><ctry>SE</ctry><ctry>SI</ctry><ctry>SK</ctry><ctry>SM</ctry><ctry>TR</ctry></B840><B860><B861><dnum><anum>CN2016099576</anum></dnum><date>20160921</date></B861><B862>en</B862></B860><B870><B871><dnum><pnum>WO2018053709</pnum></dnum><date>20180329</date><bnum>201813</bnum></B871></B870></B800></SDOBI>
</ep-patent-document>
